ACCEPTABILITY OF POINT OF CARE FINGER-STICK AND VENEPUNCTURE HEPATITIS C VIRUS TESTING AMONG PEOPLE WHO INJECT DRUGS AND HOMELESS PEOPLE


Author: Bajis S, Lamoury FMJ, Applegate TL, Maher L, Treloar C, Mowat Y, Schulz M, Hajarizadeh B, Marshall A, Cunningham EB, Cock V, Ezard N, Gorton C, Hayllar J, Smith J, Dore GJ, Grebely J

Theme: Epidemiology & Public Health Research Year: 2017

Hepatitis C virus (HCV) testing remains inadequate globally. Simplified point of care tests are urgently needed to enhance HCV diagnosis and elimination. We aimed to assess the acceptability of finger-stick whole-blood and venepuncture HCV testing among people who inject drugs (PWID) and homeless people in Australia.
Method: Participants were enrolled in an observational cohort study with recruitment at six sites between May and December 2016. Capillary whole-blood collected by finger-stick and plasma collected by venepuncture were for Xpert®HCV viral load testing. Participants completed a questionnaire on acceptability of blood collection methods.
Results: Among 297 participants (mean age, 45 years; 70% male), 39% self-reported as HCV positive and 40% tested HCV RNA positive. Overall, 70% reported ever injecting drugs, 51% injected in the last month, and 35% were receiving opioid substitution treatment. Prior to the study, 67% reported ever testing for HCV by venepuncture and 46% by finger-stick. Sixty-seven percent preferred to receive HCV test results on the same day and 94% indicated that they would be willing to wait up to 120 minutes for results. Most participants reported that finger-stick testing was somewhat or very acceptable (83%). The majority of participants preferred finger-stick over venepuncture (68%), with 70% of these preferring to receive results in 60 minutes. The most common reason for preferring finger-stick testing was that it was quick (55%) or that the nurse usually has trouble taking my blood (9%).
Conclusion:Finger-stick whole-blood collection is highly acceptable to PWID and homeless people. The further evaluation of simplified point of care HCV testing as a single-visit opportunity to engage people in care is crucial for HCV treatment scale-up to achieve HCV elimination.

Download abstract Download poster